Transitional Cell Tumor
1 clinical trials · Condition
◉ Watch Transitional Cell Tumor
| Record | Firm | Date |
|---|---|---|
| Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy (NCT05322187) | RenJi Hospital | 2022-04-10 |
Track Transitional Cell Tumor automatically
Every clearance here is in the API, with alerts when new ones post.